#news #biotech Gene editing biotech Verve indicates a swift swerve onto Wall Street, asking for $100M IPO

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Gene editing biotech Verve indicates a swift swerve onto Wall Street, asking for $100M IPO .Gene editing biotech Verve indicates a swift swerve onto Wall Street, asking for $100M IPO
badams
Tue, 06/01/2021 – 06:08

from FierceBiotech: Biotech https://ift.tt/2S1uOp1